Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma

Cancer Letters

Volumn 254, Issue 2, 2007, Pages 298-307

  Scintu, Marina ^a   Vitale, Rita ^a,b   Prencipe, Maria ^a   Pia Gallo, Antonietta ^a   Bonghi, Loriana ^a   Valori, Vanna Maria ^a   Maiello, Evaristo ^a   Rinaldi, Monica ^c   Signori, Emanuela ^c,d   Rabitti, Carla ^e   Carella, Massimo ^a   Dallapiccola, Bruno ^a   Altomare, Vittorio ^e   Fazio, Vito M ^a,d   Parrella, Paola ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c CNR   (Italy)

^d Section of Molecular Medicine and Biotechnology   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Breast cancer; BUB1B; Gene expression; Genomic instability; MAD2L1

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; BUB1B GENE; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; DIPLOIDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAD2L1 GENE; MITOSIS SPINDLE; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CARCINOMA, DUCTAL; CELL CYCLE PROTEINS; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; RNA, MESSENGER;

EID: 34547222536     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.03.021     Document Type: Article

References (41)

1. Yamamoto H., Imai K., and Perucho M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J. Gastroenterol. 37 (2002) 153-163
2. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
3. Cleaver J.E. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat. Rev. Cancer 5 (2005) 564-573
4. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
5. Yoon D.S., Wersto R.P., Zhou W., Chrest F.J., Garrett E.S., Kwon T.K., and Gabrielson E. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am. J. Pathol. 161 (2002) 391-397
6. Minhas K.M., Singh B., Jiang W.W., Sidransky D., and Califano J.A. Spindle assembly checkpoint defects and chromosomal instability in head and neck squamous cell carcinoma. Int. J. Cancer 107 (2003) 46-52
7. Lingle W.L., Barrett S.L., Negron V.C., D'Assoro A.B., Boeneman K., Liu W., Whitehead C.M., Reynolds C., and Salisbury J.L. Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. USA 99 (2002) 1978-1983
8. Storchova Z., and Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5 (2004) 45-54
9. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev. Cancer 2 (2002) 815-825
10. Jallepalli P.V., Waizenegger I.C., Bunz F., Langer S., Speicher M.R., Peters J.M., Kinzler K.W., Vogelstein B., and Lengauer C. Securin is required for chromosomal stability in human cells. Cell 105 (2001) 445-457
11. Kaplan K.B., Burds A.A., Swedlow J.R., Bekir S.S., Sorger P.K., and Nathke I.S. A role for the adenomatous polyposis coli protein in chromosome segregation. Nat. Cell. Biol. 3 (2001) 429-432
12. Green R.A., and Kaplan K.B. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J. Cell Biol. 163 (2003) 949-961
13. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., and Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
14. Kops G.J., Weaver B.A., and Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 5 (2005) 773-785
15. Ouyang B., Knauf J.A., Ain K., Nacev B., and Fagin J.A. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1. Clin. Endocrinol. (Oxf.) 56 (2002) 341-350
16. Hainsworth P.J., Raphael K.L., Stillwell R.G., Bennett R.C., and Garson O.M. Cytogenetic features of twenty-six primary breast cancers. Cancer Genet. Cytogenet. 53 (1991) 205-218
17. Pandis N., Idvall I., Bardi G., Jin Y., Gorunova L., Mertens F., Olsson H., Ingvar C., Beroukas K., Mitelman F., and Heim S. Correlation between karyotypic pattern and clincopathologic features in 125 breast cancer cases. Int. J. Cancer 66 (1996) 191-196
18. Teixeira M.R., Pandis N., Bardi G., Andersen J.A., and Heim S. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res. 56 (1996) 855-859
19. Takami S., Kawasome C., Kinoshita M., Koyama H., and Noguchi S. Chromosomal instability detected by fluorescence in situ hybridization in Japanese breast cancer patients. Clin. Chim. Acta 308 (2001) 127-131
20. Farabegoli F., Santini D., Ceccarelli C., Taffurelli M., Marrano D., and Baldini N. Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry 46 (2001) 50-56
21. Percy M.J., Myrie K.A., Neeley C.K., Azim J.N., Ethier S.P., and Petty E.M. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29 (2000) 356-362
22. Yuan B., Xu Y., Woo J.H., Wang Y., Bae Y.K., Yoon D.S., Wersto R.P., Tully E., Wilsbach K., and Gabrielson E. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 12 (2006) 405-410
23. Myrie K.A., Percy M.J., Azim J.N., Neeley C.K., and Petty E.M. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett. 152 (2000) 193-199
24. Parrella P., Xiao Y., Fliss M., Sanchez-Cespedes M., Mazzarelli P., Rinaldi M., Nicol T., Gabrielson E., Cuomo C., Cohen D., Pandit S., Spencer M., Rabitti C., Fazio V.M., and Sidransky D. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 61 (2001) 7623-7626
25. Xiao S., Renshaw A., Cibas E.S., Hudson T.J., and Fletcher J.A. Novel fluorescence in situ hybridization approaches in solid tumors. Characterization of frozen specimens, touch preparations, and cytological preparations. Am. J. Pathol. 147 (1995) 896-904
26. Parrella P., Caballero O.L., Sidransky D., and Merbs S.L. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest. Ophthalmol. Vis. Sci. 42 (2001) 1679-1684
27. Nakamura R., Song J.P., Isogaki J., Kitayama Y., and Sugimura H. Multiple (multicentric and multifocal) cancers in the ipsilateral breast with different histologies: profiles of chromosomal numerical abnormality. Jpn. J. Clin. Oncol. 33 (2003) 463-469
28. Kitayama Y., Igarashi H., and Sugimura H. Different vulnerability among chromosomes to numerical instability in gastric carcinogenesis: stage-dependent analysis by FISH with the use of microwave irradiation. Clin. Cancer Res. 6 (2000) 3139-3146
29. Kuukasjarvi T., Tanner M., Pennanen S., Karhu R., Kallioniemi O.P., and Isola J. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am. J. Pathol. 150 (1997) 1465-1471
30. Devilee P., Thierry R.F., Kievits T., Kolluri R., Hopman A.H., Willard H.F., Pearson P.L., and Cornelisse C.J. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res. 48 (1988) 5825-5830
31. Dutrillaux B., Gerbault-Seureau M., Remvikos Y., Zafrani B., and Prieur M. Breast cancer genetic evolution: I. Data from cytogenetics and DNA content. Breast Cancer Res. Treat. 19 (1991) 245-255
32. Igarashi H., Yamashita K., Suzuki M., Kitayama Y., Isogaki J., Maruyama K., Sunayama K., Tsuda H., Ozawa T., Kiyose S., and Sugimura H. Simultaneous imaging of membrane antigen and the corresponding chromosomal locus in pathology archives. Pathol. Int. 55 (2005) 753-756
33. Shichiri M., Yoshinaga K., Hisatomi H., Sugihara K., and Hirata Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62 (2002) 13-17
34. Wang X., Jin D.Y., Ng R.W., Feng H., Wong Y.C., Cheung A.L., and Tsao S.W. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62 (2002) 1662-1668
35. Dai H., van't Veer L., Lamb J., He Y.D., Mao M., Fine B.M., Bernards R., van de Vijver M., Deutsch P., Sachs A., Stoughton R., and Friend S. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res. 65 (2005) 4059-4066
36. Rouzier R., Perou C.M., Symmans W.F., Ibrahim N., Cristofanilli M., Anderson K., Hess K.R., Stec J., Ayers M., Wagner P., Morandi P., Fan C., Rabiul I., Ross J.S., Hortobagyi G.N., and Pusztai L. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res. 11 (2005) 5678-5685
37. Warren C.D., Brady D.M., Johnston R.C., Hanna J.S., Hardwick K.G., and Spencer F.A. Distinct chromosome segregation roles for spindle checkpoint proteins. Mol. Biol. Cell 13 (2002) 3029-3041
38. Kops G.J., Foltz D.R., and Cleveland D.W. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc. Natl. Acad. Sci. USA 101 (2004) 8699-8704
39. Daniels M.J., Wang Y., Lee M., and Venkitaraman A.R. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306 (2004) 876-879
40. Shen K., Wang Y., Brooks S.C., Raz A., and Wang Y.A. ATM is activated by mitotic stress and suppresses centrosome amplification in primary but not in tumor cells. J. Cell Biochem. 99 (2006) 1267-1274
41. Grigorova M., Staines J.M., Ozdag H., Caldas C., and Edwards P.A. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1. Cytogenet. Genome Res. 104 (2004) 333-340